Resources from the same session
Chemotherapy (taxanes and platins) and Radium-223, mechanism of action, main efficacy results in Castration-Resistant Prostate Cancer (CRPC) and toxicities
Presenter: E. Castro, ES
Session: Session 3 - Systemic treatment options and molecular characterisation
Resources:
Slides
Webcast
Bone health agents, mechanism of action, efficacy and toxicities
Presenter: G. Baciarello, IT
Session: Session 3 - Systemic treatment options and molecular characterisation
Resources:
Slides
Webcast
Molecular characterisation: Germline and somatic testing
Presenter: E. Castro, ES
Session: Session 3 - Systemic treatment options and molecular characterisation
Resources:
Slides
Webcast
Participants clinical case discussion: The role of precision medicine in metastatic prostate cancer: Liquid biopsy may help to personalize treatment
Presenter: J. Gavira Diaz, FR
Session: Session 3 - Systemic treatment options and molecular characterisation
Resources:
Slides
Webcast